Federal Register of Legislation - Australian Government

Primary content

PB 112 of 2010 Determinations/Health as made
This Determination amends the National Health (Listed drugs on F1 or F2) Determination 2010 (No. PB 93 of 2010) to provide for allocation of drugs to the F1 and F2 formularies for the Pharmaceutical Benefits Scheme.
Administered by: Health
Registered 30 Nov 2010
Tabling HistoryDate
Tabled HR08-Feb-2011
Tabled Senate08-Feb-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

National Health (Listed drugs on F1 or F2) Amendment Determination 2010

Instrument number PB 112 of 2010

National Health Act 1953

I, FELICITY MCNEILL, Acting First Assistant Secretary, Department of Health and Ageing, delegate of the Minister of Health and Ageing, make this Determination under subsection 85AB(1) of the National Health Act 1953.

Dated   30 November  2010

 

FELICITY MCNEILL

 

Acting First Assistant Secretary

Department of Health and Ageing

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination  2010.

         (2)   This Determination may also be cited as PB 112 of 2010.

2              Commencement

                This Determination commences on 1 December 2010.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination  2010 (PB 93 of 2010).


Schedule 1             Amendments

(Section 3)

 

[1]     Schedule 1, after item dealing with Carmustine

                  

Omit

 

          Cefepime

 

[2]     Schedule 1, after item dealing with Certolizumab pegol

                  

Insert

 

                    Cetrorelix

 

[3]     Schedule 1, after item dealing with Deferiprone

                  

Insert

 

          Degarelix

Denosumab

 

[4]     Schedule 1, after item dealing with Epoetin Beta

                  

Insert

 

          Epoetin Lambda

 

[5]     Schedule 1, after item dealing with Goserelin

                  

Omit

 

          Granisetron

 

[6]     Schedule 1, after item dealing with Hydromorphone

                  

Omit

 

          Hydroxocobalamin

 

[7]     Schedule 1, after item dealing with Lithium

                  

Omit

 

          Macrogol 3350

 

[8]     Schedule 1, after item dealing with Sunitinib

                  

Omit

          Tacrolimus

[9]     Schedule 2, after item dealing with Alendronic acid with colecalciferol

                  

Insert

 

          Alendronic acid with colecalciferol and calcium

 

[10]   Schedule 2, after item dealing with Cefalotin

                  

Insert

 

          Cefepime

 

[11]   Schedule 2, after item dealing with Glyceryl trinitrate

                  

Insert

 

          Granisetron

 

 

[12]   Schedule 2, after item dealing with Hydrocortisone

                  

Insert

 

          Hydroxocobalamin

 

[13]   Schedule 2, after item dealing with Loperamide

                  

Insert

 

          Macrogol 3350

 

[14]   Schedule 2, after item dealing with Omeprazole

                  

Insert

 

          Omeprazole and clarithromycin and amoxycillin

 

[15]   Schedule 2, after item dealing with Sumatriptan

                  

Insert

 

          Tacrolimus

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.